Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Anything under 40 cents is a no brainer...

<< Previous

Bullboard Posts

Next >>

Post by cpacon Nov 10, 2020 3:13pm

301 Views

Post# 31871780

Anything under 40 cents is a no brainer...

Chart looked to me like we had bottomed in the mid 30s... so I have nearly doubled my position and got my ACB to nearly 40c even...
This is such an easy buy under 40c so long as you have the patients to stick with it for the next 6 months. Once our phase III trial is actively underway, it's highly unlikely this trades below $1. Very easy double or triple in the medium term and potential kingmaker company in the long-term.

Cheers,
CPAC

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction